Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Immunoprecise Antibodies Ltd.

Headquarters: Victoria, BC, Canada
Year Founded: 1989
Status: Public
Industry Sector: HealthTechnology
CEO: Jennifer L. Bath, PhD
Number Of Employees: 101
Enterprise Value: $40,253,878
PE Ratio: -0.51
Exchange/Ticker 1: NASDAQ:IPA
Exchange/Ticker 2: N/A
Latest Market Cap: $9,597,600

BioCentury | Apr 23, 2022
Product Development

COVID roundup: CureVac says low-dose bivalent vaccine effective in mice

Plus updates from Clover, Selva and ImmunoPrecise Antibodies
BioCentury | Jul 30, 2021
Translation in Brief

Stanford, Tempus unveil high-throughput screening platforms; plus Blueprint, Editas, Prothena, AlzeCure and more

BioCentury’s roundup of translational news
BioCentury | Feb 22, 2020
Product Development

COVID-19 mAb menagerie

A taxonomy of mAb programs against COVID-19
BioCentury | Nov 20, 2017
Company News

Management tracks: Shire, Aveo

Items per page:
1 - 4 of 4